Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9470026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An extended-spectrum cephalosporin has been considered appropriate therapy for non-meningeal infections caused by drug-resistant Streptococcus pneumoniae. We report a toddler who had breakthrough bacteremia and meningitis develop because of drug-resistant pneumococcus while receiving treatment with cefotaxime and cefuroxime for pneumonia.
Medical subject headings
- Bacteremia
- Cephalosporin Resistance
- Cephalosporins
- Drug Resistance, Multiple
- Meningitis, Pneumococcal
- Pneumonia, Pneumococcal
- Streptococcus pneumoniae